BCOR and uterine corpus sarcoma: Recently, additional variant partners for BCOR‐fusions, including L3MBTI2, EP300, NUTM2G, RALGPS1, MAP7D2, RGAG1, ING3, NUGGC, KMT2D, and CREBBP, were identified in a series of 40 uterine sarcomas.57